Core Viewpoint - The company has completed a placement agreement totaling HKD 120 million, which will enhance its upstream manufacturing capabilities and provide additional liquidity for operations [1][2] Group 1: Fundraising Details - The placement raised a total of HKD 120 million by issuing up to 3 million shares at a price of HKD 40 per share, representing approximately 4.76% of the total share capital [2] - The placement price reflects a discount of about 10.41% compared to the closing price of HKD 44.65 on May 20, 2025, and an 11.39% discount compared to the average closing price of HKD 45.14 over the last five trading days [2] Group 2: Financial Projections - The company expects a revenue growth of 33% for the fiscal year 2025, reaching RMB 770 million, with a net profit growth of 30% to RMB 217 million [2] - The current valuation stands at 12.9 times the forecasted price-to-earnings ratio for fiscal year 2025, or 0.43 times the PEG ratio, indicating an attractive valuation compared to industry peers [2] Group 3: Market Outlook - The company is projected to achieve a year-on-year revenue growth of 27%-33% from 2025 to 2027, with a gross margin maintained between 53%-54% [1] - The stock price increased by 6.6% to HKD 47.6 as of May 21, reflecting positive market sentiment following the fundraising announcement [1]
贝克微(2149.HK)：配售完成 关注执行落地